中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

16 records (took 0.018 seconds)

    재조합 대장균을 이용한 가용성 림포톡신의 제조방법
    3.
    发明授权
    재조합 대장균을 이용한 가용성 림포톡신의 제조방법 失效
    生产LYMPHOTOXIN的方法

    公开(公告)号：KR1019950012806B1

    公开(公告)日：1995-10-21

    申请号：KR1019920007367

    申请日：1992-04-30

    Applicant: 한국과학기술연구원

    Inventor： 성문희 ,  유향숙 ,  나도선 ,  박승길 ,  최윤호 ,  한문희 ,  반재구

    IPC: C12N15/19

    Abstract: The construction of the gene of soluble lymphotoxin (I) consists of (1) extracting mRNA from RPMI 1788 cell line, (2) cloning gene of (I) with primers into plasmid pLT1, (3) mutating (I) with primers of 5'-CTC CCA GGC GTT GGT CTT ACC CCA TCA GCT GCC CAG ACT GCC CGT-3' and 5'-GGA GAC TAA GTC TTA TTA CAG AGC GAA GGC TCC AAA GAA-3', (4) transferring (3) product into plasmid pT7LT3 (KCTC 8513P) (III). After culturing E. coli having (III) at 20-21 deg.C, 11.5 mg/liter of crude (I) is harvested. (I) is useful for anticancer.

    Abstract translation: 可溶性淋巴毒素（I）基因的构建由（1）从RPMI 1788细胞系提取mRNA，（2）将引物（I）的克隆基因引入质粒pLT1，（3）突变（I）引物5 '-CTC CCA GGC GTT GGT CTT ACC CCA TCA GCT GCC CAG ACT GCC CGT-3'和5'-GGA GAC TAA GTC TTA TTA CAG AGC GAA GGC TCC AAA GAA-3'，（4）将（3）产物转移 质粒pT7LT3（KCTC 8513P）（III）。 在20-21℃培养具有（III）的大肠杆菌后，收获11.5mg / l的原油（I）。 （I）对抗癌有用。

    사람 인터루킨-2 단백질을 생산하는 담배식물체와 그의 제조방법
    5.
    发明授权
    사람 인터루킨-2 단백질을 생산하는 담배식물체와 그의 제조방법 失效
    产生人白细胞介素-2蛋白质的烟草植物及其生产方法

    公开(公告)号：KR1019930009562B1

    公开(公告)日：1993-10-07

    申请号：KR1019910007224

    申请日：1991-05-03

    Applicant: 한국과학기술연구원

    Inventor： 홍주봉 ,  조혜선 ,  이혜주 ,  한문희 ,  나도선

    IPC: C12N15/82

    Abstract: The method for producing human interleukin-2 protein in a tobacco tissue comprises: (a) inserting human interleukin-2 gene into a vector pBKS-1 to obtain a recombinant plasmid DNA; (b) transforming it into Agrobacterium tumefaciens; (c) adding the transformants into tobacco leaves callus and culturing at 25 deg.C for 1-2 days in a dark place; (d) washing it with MS medium and culturing in a selective medium containing kanamycin and carbenicillin; (e) culturing it to obtain a tobacco tissue (KCTC 8499P), producing human interleukin-2 protein.

    Abstract translation: 在烟草组织中产生人白介素-2蛋白的方法包括：（a）将人白细胞介素-2基因插入载体pBKS-1中以获得重组质粒DNA; （b）将其转化为根癌土壤杆菌; （c）将转化体加入烟草叶愈伤组织，并在黑暗的地方在25℃下培养1-2天; （d）用MS培养基洗涤并在含有卡那霉素和羧苄青霉素的选择培养基中培养; （e）培养以获得烟草组织（KCTC 8499P），产生人白细胞介素-2蛋白。

    인체 리포코틴을 E. coli에서 생산시 가용성인 상태로 생산 정제하는 방법 및 인체 리포코틴 cDNA 서열을 함유하는 벡터
    7.
    发明授权
    인체 리포코틴을 E. coli에서 생산시 가용성인 상태로 생산 정제하는 방법 및 인체 리포코틴 cDNA 서열을 함유하는 벡터 失效
    过程制备LIPOCORTIN的可溶性状态

    公开(公告)号：KR1019910002855B1

    公开(公告)日：1991-05-06

    申请号：KR1019890000223

    申请日：1989-01-11

    Applicant: 한국과학기술연구원

    Inventor： 나도선 ,  박순희 ,  강성만 ,  허광태

    IPC: C12N15/00

    Abstract: A process for production of plasmid pLCI comprises (a) isolating mRNA from human placentatissue, (b) preparing 2 chains of cDNA from the obtd. mRNA, (c) attaching (dC)n tail to the cDNA and subjecting it to recombination with plasmid vector, (d) transforimg E. coli with the recombinant plasmid, and (e) selecting clones having human lipocortin I coding gene in the transformant E. coli. Using the plasmid pLCI, human lipocortin I can be produced in soluble form. Lipocortin is useful as an anti-inflammatory protein.

    Abstract translation: 生产质粒pLCI的方法包括（a）从人胎盘组织中分离mRNA，（b）从该实验室制备2条cDNA链。 mRNA，（c）将（dC）n尾连接到cDNA上并使其与质粒载体重组，（d）用重组质粒转导大肠杆菌，和（e）在转化体中选择具有人脂蛋白I编码基因的克隆 大肠杆菌 使用质粒pLCI，人脂蛋白I可以以可溶形式生产。 脂皮素可用作抗炎蛋白。

Patent Agency Ranking